Human Epidermal Growth Factor Receptor 2 Overexpression and Amplification in Patients With Colorectal Cancer: A Large-Scale Retrospective Study in Chinese Population

Shujuan Ni(Shanghai Medical College of Fudan University), Weiqi Sheng(Shanghai Medical College of Fudan University), Hui Sun(Fudan University), Midie Xu(Shanghai Medical College of Fudan University), Xu Wang(Jiangsu University of Science and Technology), Zhaohui Huang(Jiangnan University), Xin Wang(Jiangsu University), Meng Zhang(Shanghai Medical College of Fudan University), Weiwei Weng(Shanghai Medical College of Fudan University), Cong Tan(Shanghai Medical College of Fudan University), Dan Huang(Chinese PLA General Hospital), Lei Wang(Shanghai Jiao Tong University), Jinjia Chang(Fudan University Shanghai Cancer Center)
Frontiers in Oncology
April 28, 2022
10.3389/fonc.2022.842787
Cited by 13

Related Papers

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
|International Journal of Cancer|2009|979
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436